Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Tenax Therapeutics, Inc.

NASDAQ: TENX · Life Sciences · 3 alerts · CIK 34956

Share price
$1.48Close, Nov 16
Market cap
$67.4M
Shares outstanding
45.54MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Tenax Therapeutics, Inc. filings on SEC EDGAR ↗

4:16 PM ET 8-K
Investor Presentation

Tenax Therapeutics Investor Presentation

Tenax Therapeutics filed an updated investor presentation detailing strategic changes to its Phase 3 LEVEL-2 clinical trial for TNX-103 in PH-HFpEF. The company is pausing enrollment to amend protocol criteria based on findings from its completed LEVEL trial and has requested a Type C meeting with the FDA to discuss the development path.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.